Navigation Links
Mouse Study Reveals How Smoking Helps Keep People Thin
Date:6/9/2011

By Amanda Gardner
HealthDay Reporter

THURSDAY, June 9 (HealthDay News) -- The notion that smoking somehow helps keep smokers thin has gotten new support from a study in mice -- and the finding might one day be parlayed into new drugs to control weight gain.

It's always a leap to extrapolate from animal experiments, one expert said, but this new research does open up interesting possibilities.

"Humans have basically the receptors as mice," noted Ursula Winzer-Serhan, an associate professor of neuroscience and experimental therapeutics at the Texas A&M Health Science Center College of Medicine in Bryan. "There is good evidence that what happens in mice also happens in humans."

Winzer-Serhan was not involved with the study, which appears in the June 10 issue of Science.

"We have to be very cautious," added study author Yann Mineur, but the basic biology, "as far as we can tell, is fairly similar to what's happening in humans."

It's well known that people who smoke tend to be skinnier, even if their lives tend to be shorter than those of nonsmokers.

"All animal studies show that nicotine reduces body weight by reducing food intake and increasing energy expenditure," said Winzer-Serhan. "That is one of the few facts in science there is not a lot of controversy about."

But the new study goes deeper than that. Mineur, an associate research scientist in psychiatry at Yale School of Medicine, stumbled upon the compound used in the study, cytisine, while looking into possible drugs for depression.

The smoking-cessation drug Chantix (varenicline) is a derivative of cytisine.

In experiments with mice, cytisine prevented weight gain by activating the same set of neurons in the hypothalamus as nicotine does. This neurological pathway is also involved in appetite and metabolism, the researchers said.

However, even though the idea of targeting nicotine receptors to control weight has been around a long time, the problem is that nicotine receptors are located all over the body, explained William Tank, chair of pharmacology and physiology at the University of Rochester Medical Center.

That means that any drug developed to control weight via nicotinic receptors would have to be very targeted, otherwise it could have effects on other parts of the body, including memory, blood pressure and heart beat, explained Winzer-Serhan.

Cytisine, which Mineur says is already used in some Eastern European countries as a smoking-cessation aid, is fairly selective, targeting receptors in the peripheral nervous system.

In the meantime, the current findings should not be used to encourage smoking as a weight-loss tool, given the habit's deadly effects.

Certain nicotine-based, smoking-cessation techniques, such as patches, could potentially limit weight gain, Mineur says, but smoking is not the way to go.

Mineur also pointed out that there are many other factors associated with post-smoking weight gain, such as munching on candy because you miss the cigarette.

"The idea of there being a therapeutic use of nicotine agonists is . . . a great idea," said Tank. "[But] this is a very complicated set of physiologies and nicotine is an extraordinarily complicated drug."

More information

For help on quitting smoking, head to the American Lung Association.

SOURCES: Yann Mineur, Ph.D., associate research scientist in psychiatry, Yale School of Medicine, New Haven, Conn.; William Tank, Ph.D., professor and chair, pharmacology and physiology, University of Rochester Medical Center; Ursula Winzer-Serhan, Ph.D., associate professor, neuroscience and experimental therapeutics, Texas A&M Health Science Center College of Medicine, Bryan; June 10, 2011, Science


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Apples Help Keep Muscles Strong, Mouse Study Finds
2. Scientists create humanized mouse model for hepatitis C
3. Pitt researchers build a better mouse model to study depression
4. Mouse study turns fat-loss/longevity link on its head
5. Fox Chase researchers report that naproxen reduces tumors in a mouse model of colon cancer
6. Sleeping through danger: the dormouse approach to survival
7. Mouse Sperm Successfully Grown in Lab, Researchers Say
8. Mouse cancer genome unveils genetic errors in human cancers
9. Malaria drug slows pancreatic cancer growth in mouse models
10. New mouse model explains common pediatric brain tumor
11. Mouse nose nerve cells mature after birth, allowing bonding, recognition with mother
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mouse Study Reveals How Smoking Helps Keep People Thin
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... PASADENA, CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. ... he would lash out at his family verbally and physically. , “When something upset him, ... table, he would use it. He would throw rocks at my other children and say ...
(Date:6/24/2016)... ... ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys are ... for this recognition are considered among the top 2 percent of lawyers practicing within ... of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. Bloom, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... ANGELES , June 23, 2016 ... CAPR ), a biotechnology company focused ... therapeutics, today announced that patient enrollment in its ... in Duchenne) has exceeded 50% of its 24-patient ... enrollment in the third quarter of 2016, and ...
Breaking Medicine Technology: